Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06604442 · ClinicalTrials.gov registry record · Phase 4

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

A Phase 4 study of Prostate Cancer, sponsored by Blue Earth Diagnostics.

Completed
Registry status
Phase 4
Development phase
55
Enrollment target
9
Study locations

NCT06604442 is a Phase 4 study of Prostate Cancer that has completed, run by Blue Earth Diagnostics. The registered enrollment target is 55 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The trial reports 9 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06604442, a Phase 4 study of Prostate Cancer, has completed, sponsored by Blue Earth Diagnostics.

COMPLETED
Registry status
Phase 4
Development phase
55 participants
Enrollment target
9
Study locations

Study Summary

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

Conditions Studied

Prostate Cancer

Interventions

  • DRUG Flotufolastat (18F)
  • DRUG piflufolastat (18F)

Study Locations (9)

California

  • City of Hope Medical Center - Duarte
  • Tower Urology - Los Angeles

Arizona

  • Mayo Clinic - Phoenix

Florida

  • Mayo Clinic - Jacksonville

Illinois

  • Endeavor Health- Glenbrook Hospital - Glenview

Nebraska

  • XCancer Omaha/Urology Cancer Center - Omaha

New York

  • Montefiore Medical Center - The Bronx

Ohio

  • Cleveland Clinic - Cleveland

Texas

  • Urology San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2024-12-04
Est. Completion 2025-08-29
Phase Phase 4

Sponsor

Blue Earth Diagnostics

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06604442

The ClinicalTrials.gov registry entry for NCT06604442 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (91% lower). The listed sponsor is Blue Earth Diagnostics, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Flotufolastat (18F) is the first listed.

NCT06604442 reports 9 study locations spanning 8 distinct geographic areas - top geographies include California, Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT06604442 about?

NCT06604442 is a clinical study titled "Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy". Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

What is the current status of trial NCT06604442?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 55 participants. The study started on 2024-12-04. Estimated completion is 2025-08-29.

What conditions does trial NCT06604442 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT06604442?

The interventions under investigation include: Flotufolastat (18F) (DRUG), piflufolastat (18F) (DRUG).

Who is sponsoring clinical trial NCT06604442?

This trial is sponsored by Blue Earth Diagnostics, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06604442 being conducted?

This trial has 9 study locations across Arizona, California, Florida, Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.